DAX
15.150,03 +17,18 (+0,11%) Euro Stoxx 50
4.178,01 +4,03 (+0,10%) Dow Jones 30
34.046,83 +97,42 (+0,29%) Gold
1.929,60 -0,40 (-0,02%) EUR/USD
1,0864 -0,0028 (-0,26%) BTC-EUR
21.321,70 -37,60 (-0,18%)
Gilead Sciences, Inc. (GIS.F)
| Kurs Vortag | 76,37 |
| Öffnen | 76,38 |
| Gebot | 77,02 x 50000 |
| Briefkurs | 77,08 x 50000 |
| Tagesspanne | 76,38 - 76,54 |
| 52-Wochen-Spanne | 52,23 - 84,73 |
| Volumen | |
| Durchschn. Volumen | 1.669 |
| Marktkap. | 96,722B |
| Beta (5 J., monatlich) | 0,43 |
| Kurs-Gewinn-Verhältnis (roll. Hochrechn.) | 31,63 |
| EPS (roll. Hochrechn.) | 2,42 |
| Gewinndatum | 02. Feb. 2023 |
| Erwartete Dividende & Rendite | 2,75 (3,58%) |
| Ex-Dividendendatum | 14. Dez. 2022 |
| 1-Jahres-Kursziel | N/A |
- ACCESSWIRE
Gilead Sciences: A Career Rooted in Championing Diversity and Inclusion: Jesse's Story
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
- ACCESSWIRE
Gilead's Path to Equitable Global COVID-19 Treatment Access
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
- ACCESSWIRE
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.
